Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotem Karni

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Opinion in Genetics & Development|October 29, 2017
The role of alternative splicing in cancer drug resistanceZahava Siegfried, Rotem Karni
Molecular & Cellular Oncology|June 17, 2016
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionAsaf Shilo, Zahava Siegfried, Rotem Karni
The FEBS Journal|April 27, 2007
Subunit S5a of the 26S proteasome is regulated by antiapoptotic signalsYael Gus, Rotem Karni, Alexander Levitzki
Current Opinion in Pharmacology|July 4, 2021
Splice-switching as cancer therapyAmina Jbara, Zahava Siegfried, Rotem Karni
RNA (New York, N.Y.)|January 25, 2023
Targeting splicing factors for cancer therapyAriel Bashari, Zahava Siegfried, Rotem Karni
Trends in Cancer|November 22, 2024
Generation of tumor neoantigens by RNA splicing perturbationAdi Rosenberg-Mogilevsky, Zahava Siegfried, Rotem Karni
International Journal of Cell Biology|October 1, 2013
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerZahava Siegfried, Serena Bonomi, Claudia Ghigna, et al.
Bioconjugate Chemistry|December 7, 2017
CLIP6-PNA-Peptide Conjugates: Non-Endosomal Delivery of Splice Switching OligonucleotidesTerese Soudah, Maxim Mogilevsky, Rotem Karni, et al.
Human Genetics|April 22, 2017
The role of RNA alternative splicing in regulating cancer metabolismItamar Kozlovski, Zahava Siegfried, Adi Amar-Schwartz, et al.
Molecular and Cellular Biology|June 1, 2005
Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translationRotem Karni, Yael Gus, Yuval Dor, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Opinion in Genetics & Development|October 29, 2017
The role of alternative splicing in cancer drug resistanceZahava Siegfried, Rotem Karni
Molecular & Cellular Oncology|June 17, 2016
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionAsaf Shilo, Zahava Siegfried, Rotem Karni
The FEBS Journal|April 27, 2007
Subunit S5a of the 26S proteasome is regulated by antiapoptotic signalsYael Gus, Rotem Karni, Alexander Levitzki
Current Opinion in Pharmacology|July 4, 2021
Splice-switching as cancer therapyAmina Jbara, Zahava Siegfried, Rotem Karni
RNA (New York, N.Y.)|January 25, 2023
Targeting splicing factors for cancer therapyAriel Bashari, Zahava Siegfried, Rotem Karni
Trends in Cancer|November 22, 2024
Generation of tumor neoantigens by RNA splicing perturbationAdi Rosenberg-Mogilevsky, Zahava Siegfried, Rotem Karni
International Journal of Cell Biology|October 1, 2013
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerZahava Siegfried, Serena Bonomi, Claudia Ghigna, et al.
Bioconjugate Chemistry|December 7, 2017
CLIP6-PNA-Peptide Conjugates: Non-Endosomal Delivery of Splice Switching OligonucleotidesTerese Soudah, Maxim Mogilevsky, Rotem Karni, et al.
Human Genetics|April 22, 2017
The role of RNA alternative splicing in regulating cancer metabolismItamar Kozlovski, Zahava Siegfried, Adi Amar-Schwartz, et al.
Molecular and Cellular Biology|June 1, 2005
Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translationRotem Karni, Yael Gus, Yuval Dor, et al.
Pageof 6